Follow the メディキット株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, メディキット株式会社 has recorded 13 reports. Market capitalisation: €40.6bn. The latest transaction was reported on 26 August 2025 (Holding update). Among the most active insiders: Takashi Nakajima. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,796 of 29,062 companies
71.3
score / 100
Value
73
Quality
69
FCF yld3.1%
Earn yld7.4%
EV/EBITDA6.2x
ROE6.5%
Gross mgn38%
Net mgn13%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Medikit es una empresa especializada en el sector de la salud y farmacéutico, cotizada en el mercado XTKS. Se enfoca en el desarrollo y la fabricación de productos médicos y farmacéuticos.